# Alexandria Real Estate Equities' Biotech Investments: 78 Startups in Its Portfolio (2026) > The 78 Biotech startups Alexandria Real Estate Equities has backed, by stage: $7.4B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/alexandria-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 27 - [Editas Medicine](https://millionrounds.com/company/editas-medicine) - [Strand Therapeutics](https://millionrounds.com/company/strand-therapeutics) - [Stoke Therapeutics](https://millionrounds.com/company/stoke-therapeutics) - [*CT* Capstan Therapeutics](https://millionrounds.com/company/capstan-therapeutics) - [Homology Medicines](https://millionrounds.com/company/homology-medicines) - [Sidewinder Therapeutics](https://millionrounds.com/company/sidewinder-therapeutics) - [Syros Pharmaceuticals](https://millionrounds.com/company/syros-pharmaceuticals) - [SonoThera](https://millionrounds.com/company/sonothera) - [*T* TCR2](https://millionrounds.com/company/tcr2) - [Arrakis Therapeutics](https://millionrounds.com/company/arrakis-therapeutics) - [ImCheck Therapeutics](https://millionrounds.com/company/imcheck-therapeutics) - [Kallyope](https://millionrounds.com/company/kallyope) - [*I* Ideaya](https://millionrounds.com/company/ideaya) - [Gritstone](https://millionrounds.com/company/gritstone) - [BlackThorn Therapeutics](https://millionrounds.com/company/blackthorn-therapeutics) - [Evelo Biosciences](https://millionrounds.com/company/evelo-biosciences) - [Atara Biotherapeutics](https://millionrounds.com/company/atara-biotherapeutics) - [*KT* Karuna Therapeutics](https://millionrounds.com/company/karuna-therapeutics) - [*PT* Prevail Therapeutics](https://millionrounds.com/company/prevail-therapeutics) - [*N* Nohla](https://millionrounds.com/company/nohla) - [*A* Allozyne](https://millionrounds.com/company/allozyne) - [Thryv Therapeutics](https://millionrounds.com/company/thryv-therapeutics) - [Immusoft](https://millionrounds.com/company/immusoft) - [NextCure](https://millionrounds.com/company/nextcure) +3 more ## Series A 22 - [Jasper Therapeutics](https://millionrounds.com/company/jasper-therapeutics) - [*P* Prevail](https://millionrounds.com/company/prevail) - [Celsius](https://millionrounds.com/company/celsius) - [*X* X-Vax](https://millionrounds.com/company/x-vax) - [*E* Expansion](https://millionrounds.com/company/expansion) - [Quentis Therapeutics](https://millionrounds.com/company/quentis-therapeutics) - [Ribometrix](https://millionrounds.com/company/ribometrix) - [*V* Vtesse](https://millionrounds.com/company/vtesse) - [*I* Immunitas](https://millionrounds.com/company/immunitas) - [Silverback Therapeutics](https://millionrounds.com/company/silverback-therapeutics) - [*MN* Magnolia Neuroscience](https://millionrounds.com/company/magnolia-neuroscience) - [*TT* Tiburio Therapeutics](https://millionrounds.com/company/tiburio-therapeutics) - [March Biosciences](https://millionrounds.com/company/march-biosciences) - [*RT* Rheostat Therapeutics](https://millionrounds.com/company/rheostat-therapeutics) - [Forge Therapeutics](https://millionrounds.com/company/forge-therapeutics) - [Cradle Genomics](https://millionrounds.com/company/cradle-genomics) - [Molecular Assemblies](https://millionrounds.com/company/molecular-assemblies) - [StrideBio](https://millionrounds.com/company/stridebio) - [Gencove](https://millionrounds.com/company/gencove) - [*B* Boragen](https://millionrounds.com/company/boragen) - [Cardea Bio](https://millionrounds.com/company/cardea-bio) - [*AT* Acylin Therapeutics](https://millionrounds.com/company/acylin-therapeutics) ## Series C and later 18 - [Moderna](https://millionrounds.com/company/moderna) - [Eikon Therapeutics](https://millionrounds.com/company/eikon-therapeutics) - [*E* eGenesis](https://millionrounds.com/company/egenesis) - [LifeMine Therapeutics](https://millionrounds.com/company/lifemine-therapeutics) - [Obsidian Therapeutics](https://millionrounds.com/company/obsidian-therapeutics) - [Dewpoint Therapeutics](https://millionrounds.com/company/dewpoint-therapeutics) - [Metacrine](https://millionrounds.com/company/metacrine) - [KSQ Therapeutics](https://millionrounds.com/company/ksq-therapeutics) - [Boundless Bio](https://millionrounds.com/company/boundless-bio) - [Aspen Neuroscience](https://millionrounds.com/company/aspen-neuroscience) - [Visterra](https://millionrounds.com/company/visterra) - [*AB* Aura Biosciences](https://millionrounds.com/company/aura-biosciences) - [Integrated Diagnostics](https://millionrounds.com/company/integrated-diagnostics) - [*R* Rgenix](https://millionrounds.com/company/rgenix) - [*C* Codiak](https://millionrounds.com/company/codiak) - [Arsanis](https://millionrounds.com/company/arsanis) - [Antiva Biosciences](https://millionrounds.com/company/antiva-biosciences) - [*GH* GNS Healthcare](https://millionrounds.com/company/gns-healthcare) ## Stage not reported 11 - [*P* Precision](https://millionrounds.com/company/precision) - [Metabolon](https://millionrounds.com/company/metabolon) - [Frequency Therapeutics](https://millionrounds.com/company/frequency-therapeutics) - [HAYA Therapeutics](https://millionrounds.com/company/haya-therapeutics) - [*C* Cydan](https://millionrounds.com/company/cydan) - [*GB* GreenLigh Biosciences](https://millionrounds.com/company/greenligh-biosciences) - [Veralox Therapeutics](https://millionrounds.com/company/veralox-therapeutics) - [Kytopen](https://millionrounds.com/company/kytopen) - [*RT* Rodeo Therapeutics](https://millionrounds.com/company/rodeo-therapeutics) - [*AP* Adaptive Phage](https://millionrounds.com/company/adaptive-phage) - [*OC* Oncofactor Corporation](https://millionrounds.com/company/oncofactor-corporation) ## Segment by segment ### Series B 27 startups · $2.7B raised - [**Editas Medicine**](https://millionrounds.com/company/editas-medicine) Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases. United States $335M - [**Strand Therapeutics**](https://millionrounds.com/company/strand-therapeutics) Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments. United States $267M - [**Stoke Therapeutics**](https://millionrounds.com/company/stoke-therapeutics) Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment. United States $255M - [*CT* **Capstan Therapeutics**](https://millionrounds.com/company/capstan-therapeutics) Capstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases. United States $175M - [**Homology Medicines**](https://millionrounds.com/company/homology-medicines) Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases. United States $144M - [**Sidewinder Therapeutics**](https://millionrounds.com/company/sidewinder-therapeutics) Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases. United States $137M - [**Syros Pharmaceuticals**](https://millionrounds.com/company/syros-pharmaceuticals) Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits. United States $128M - [**SonoThera**](https://millionrounds.com/company/sonothera) SonoThera is a biotechnology company based in South San Francisco that focuses on developing ultrasound-guided, nonviral gene therapies. United States $125M ### Series A 22 startups · $853M raised - [**Jasper Therapeutics**](https://millionrounds.com/company/jasper-therapeutics) Jasper Therapeutics is a biotechnology company that develops novel antibody therapies for stem cell transplants. United States $167M - [*P* **Prevail**](https://millionrounds.com/company/prevail) - $75M - [**Celsius**](https://millionrounds.com/company/celsius) Celsius Network is a decentralized financial services platform founded in 2017, focused on bridging traditional finance and blockc United States $65M - [*X* **X-Vax**](https://millionrounds.com/company/x-vax) United States $56M - [*E* **Expansion**](https://millionrounds.com/company/expansion) United States $55M - [**Quentis Therapeutics**](https://millionrounds.com/company/quentis-therapeutics) Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. United States $49M - [**Ribometrix**](https://millionrounds.com/company/ribometrix) Ribometrix is a platform therapeutics company that discovers small molecule drugs to treat human diseases. United States $45M - [*V* **Vtesse**](https://millionrounds.com/company/vtesse) United States $42M ### Series C and later 18 startups · $3.3B raised - [**Moderna**](https://millionrounds.com/company/moderna) Learn how we’re changing the world of medicine. United States $675M - [**Eikon Therapeutics**](https://millionrounds.com/company/eikon-therapeutics) Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery. United States $351M - [*E* **eGenesis**](https://millionrounds.com/company/egenesis) United States $329M - [**LifeMine Therapeutics**](https://millionrounds.com/company/lifemine-therapeutics) LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines. United States $230M - [**Obsidian Therapeutics**](https://millionrounds.com/company/obsidian-therapeutics) Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy. United States $210M - [**Dewpoint Therapeutics**](https://millionrounds.com/company/dewpoint-therapeutics) Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. United States $196M - [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M - [**KSQ Therapeutics**](https://millionrounds.com/company/ksq-therapeutics) KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development. United States $156M ### Stage not reported 11 startups · $549M raised - [*P* **Precision**](https://millionrounds.com/company/precision) United States $111M - [**Metabolon**](https://millionrounds.com/company/metabolon) Metabolon offers metabolomics solutions that enhance life sciences research, diagnostics, and precision medicine. United States $86M - [**Frequency Therapeutics**](https://millionrounds.com/company/frequency-therapeutics) Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. United States $74M - [**HAYA Therapeutics**](https://millionrounds.com/company/haya-therapeutics) HAYA Therapeutics, SA is a precision medicine and biotechnology company focused on developing innovative genomic medicines. Switzerland $67M - [*C* **Cydan**](https://millionrounds.com/company/cydan) United States $60M - [*GB* **GreenLigh Biosciences**](https://millionrounds.com/company/greenligh-biosciences) United States $50M - [**Veralox Therapeutics**](https://millionrounds.com/company/veralox-therapeutics) VERALOX Therapeutics is a clinical-stage biotechnology company based in Frederick, Maryland. United States $41M - [**Kytopen**](https://millionrounds.com/company/kytopen) Kytopen is a biotechnology company based in Cambridge, Massachusetts, founded in 2017 as an MIT spin-out. United States $35M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Alexandria Real Estate Equities as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Alexandria Real Estate Equities** 105 co-investors](https://millionrounds.com/portfolio-maps/alexandria-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **Sequoia Capital's AI portfolio** 209 startups · $543B](https://millionrounds.com/portfolio-maps/sequoia-capital-ai-portfolio) ## Raising from investors like Alexandria Real Estate Equities? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)